STRIDES PHARMA SCIENCE LTD.

NSE : STARBSE : 532531ISIN CODE : INE939A01011Industry : Pharmaceuticals & DrugsHouse : Private
BSE879.05-3.1 (-0.35 %)
PREV CLOSE ( ) 882.15
OPEN PRICE ( ) 879.50
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 24503
TODAY'S LOW / HIGH ( )870.75 901.35
52 WK LOW / HIGH ( )330.35 903.8
NSE883.451.75 (+0.2 %)
PREV CLOSE( ) 881.70
OPEN PRICE ( ) 883.70
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 883.45 (244)
VOLUME 185948
TODAY'S LOW / HIGH( ) 873.45 901.00
52 WK LOW / HIGH ( )330 902.4
( in Million)
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Profit Before Tax-2676.31-6525.132893.80485.083443.65
Adjustment6821.925822.743633.155274.87945.92
Changes In working Capital-4577.95-1899.04-3280.54-3262.30-3231.41
Cash Flow after changes in Working Capital-432.34-2601.433246.412497.651158.16
Cash Flow from Operating Activities444.11-2578.154814.372047.87600.55
Cash Flow from Investing Activities3024.74-1187.33-5208.2113061.59-1484.93
Cash Flow from Financing Activities-2139.214213.16-157.96-17094.491942.67
Net Cash Inflow / Outflow1329.64447.68-551.80-1985.031058.29
Opening Cash & Cash Equivalents1707.301258.341822.343658.892561.62
Cash & Cash Equivalent on Amalgamation / Take over / MergerNANANANANA
Cash & Cash Equivalent of Subsidiaries under liquidations-3.39NANANANA
Translation adjustment on reserves / op cash balalces frgn subsidiariesNANANANANA
Effect of Foreign Exchange Fluctuations1.461.28-12.20148.4838.98
Closing Cash & Cash Equivalent3035.011707.301258.341822.343658.89

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.